Highlights Quince Therapeutics, Inc.

Equities

QNCX

US22053A1079

Market Closed - Nasdaq Other stock markets 21:00:00 08/05/2024 BST			5-day change	1st Jan Change
0.91 ^USD	-1.09%		-14.95%	-13.33%

04-01	Quince Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
03-26	Transcript : Quince Therapeutics, Inc. - Special Call

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Quince Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-01	CI
Quince Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Quince Therapeutics, Inc. acquired EryDel S.p.A	22/10/23	CI
Quince Therapeutics, Inc. Announces That U.S. Food and Drug Administration Lifts the Partial Clinical Hold on Erydel S.P. A's Investigational New Drug Application for Its Lead Phase 3 Asset, Erydex	28/09/23	CI
Quince Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	03/08/23	CI
Quince Therapeutics to Acquire EryDel in All-Stock Deal	24/07/23	MT
Quince Therapeutics, Inc. agreed to acquire EryDel S.p.A. for approximately $510 million.	23/07/23	CI
Quince Therapeutics Shares Rise Pre-Bell After Echo Lake Capital Raises Acquisition Offer	13/07/23	MT
Quince Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
Biomed Industries, Inc. submitted a proposal to acquire Quince Therapeutics, Inc. for $94 million.	02/05/23	CI
Quince Therapeutics Rejects Acquisition Proposal From Echo Lake Capital	11/04/23	MT
Echo Lake Capital cancelled the acquisition of Quince Therapeutics, Inc..	10/04/23	CI
Quince Therapeutics Adopts Limited Duration Stockholders Rights Plan; Sets Dividend Distribution	05/04/23	MT
Fed Rate Announcement Eyed as Exchange-Traded Funds, Equity Futures Mixed Premarket Wednesday	22/03/23	MT
Quince Therapeutics Confirms Echo Lake Capital Offer; Says to 'Carefully' Review Proposal	22/03/23	MT
Quince Therapeutics' Shares Rise Past 65% Pre-Bell Following Buyout Proposal From Echo Lake Capital	21/03/23	MT
Echo Lake Capital made an offer to acquire Quince Therapeutics, Inc. for $58.8 million.	20/03/23	CI
Quince Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	09/11/22	CI
Quince Therapeutics, Inc. Presents Preclinical Data at OI 2022 Demonstrating Potential of a Targeted Anabolic for Accelerated Bone Healing of Osteogenesis Imperfecta Fractures	30/08/22	CI
Quince Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	09/08/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Quince Therapeutics, Inc.

Equities

QNCX

US22053A1079

Highlights

Filters